BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells: Consequences for Adoptive T-Cell Therapy
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Erlangen
Friedrich-Alexander-Universität Erlangen-Nürnberg
2018
|
| Schlagworte: | |
| Online-Zugang: | Volltext Volltext Volltext |
| Beschreibung: | 1 Online-Ressource |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045911623 | ||
| 003 | DE-604 | ||
| 005 | 20190730 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190605s2018 gw |||| o||u| ||||||eng d | ||
| 015 | |a 19,O06 |2 dnb | ||
| 016 | 7 | |a 1186378492 |2 DE-101 | |
| 024 | 7 | |a urn:nbn:de:bvb:29-opus4-108494 |2 urn | |
| 035 | |a (OCoLC)1111874471 | ||
| 035 | |a (DE-599)DNB1186378492 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 044 | |a gw |c XA-DE-BY | ||
| 049 | |a DE-29 | ||
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Dörrie, Jan |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells |b Consequences for Adoptive T-Cell Therapy |c Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft |
| 264 | 1 | |a Erlangen |b Friedrich-Alexander-Universität Erlangen-Nürnberg |c 2018 | |
| 300 | |a 1 Online-Ressource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 583 | 1 | |a Archivierung/Langzeitarchivierung gewährleistet |5 DE-101 |2 pdager | |
| 653 | |a BRAF inhibitor | ||
| 653 | |a MEK inhibitor | ||
| 653 | |a kinase inhibitor | ||
| 653 | |a CAR-T cell | ||
| 653 | |a dabrafenib | ||
| 653 | |a trametinib | ||
| 653 | |a vemurafenib | ||
| 653 | |a cobimetinib | ||
| 653 | |a melanoma | ||
| 653 | |a immunotherapy | ||
| 700 | 1 | |a Babalija, Lek |e Verfasser |4 aut | |
| 700 | 1 | |a Hoyer, Stefanie |e Verfasser |4 aut | |
| 700 | 1 | |a Gerer, Kerstin F. |e Verfasser |4 aut | |
| 700 | 1 | |a Schuler, Gerold |e Verfasser |4 aut | |
| 700 | 1 | |a Heinzerling, Lucie |e Verfasser |4 aut | |
| 700 | 1 | |a Schaft, Niels |e Verfasser |4 aut | |
| 787 | 0 | 8 | |i Sonderdruck aus |t International Journal of Molecular Sciences |g Vol. 19 (2018) |o 10.3390/ijms19010289 |
| 856 | 4 | 0 | |u https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u http://d-nb.info/1186378492/34 |x Langzeitarchivierung Nationalbibliothek |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://open.fau.de/handle/openfau/10849 |x Verlag |z kostenfrei |3 Volltext |
| 912 | |a ebook | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031294188 | ||
Datensatz im Suchindex
| _version_ | 1804180083452149760 |
|---|---|
| any_adam_object | |
| author | Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels |
| author_facet | Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels |
| author_role | aut aut aut aut aut aut aut |
| author_sort | Dörrie, Jan |
| author_variant | j d jd l b lb s h sh k f g kf kfg g s gs l h lh n s ns |
| building | Verbundindex |
| bvnumber | BV045911623 |
| collection | ebook |
| ctrlnum | (OCoLC)1111874471 (DE-599)DNB1186378492 |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02145nmm a2200565zc 4500</leader><controlfield tag="001">BV045911623</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20190730 </controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190605s2018 gw |||| o||u| ||||||eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">19,O06</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">1186378492</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">urn:nbn:de:bvb:29-opus4-108494</subfield><subfield code="2">urn</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1111874471</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB1186378492</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Dörrie, Jan</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells</subfield><subfield code="b">Consequences for Adoptive T-Cell Therapy</subfield><subfield code="c">Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Erlangen</subfield><subfield code="b">Friedrich-Alexander-Universität Erlangen-Nürnberg</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="583" ind1="1" ind2=" "><subfield code="a">Archivierung/Langzeitarchivierung gewährleistet</subfield><subfield code="5">DE-101</subfield><subfield code="2">pdager</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BRAF inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MEK inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">kinase inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CAR-T cell</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">dabrafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trametinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">vemurafenib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cobimetinib</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melanoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Babalija, Lek</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hoyer, Stefanie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gerer, Kerstin F.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schuler, Gerold</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Heinzerling, Lucie</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schaft, Niels</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="787" ind1="0" ind2="8"><subfield code="i">Sonderdruck aus</subfield><subfield code="t">International Journal of Molecular Sciences</subfield><subfield code="g">Vol. 19 (2018)</subfield><subfield code="o">10.3390/ijms19010289</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494</subfield><subfield code="x">Resolving-System</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://d-nb.info/1186378492/34</subfield><subfield code="x">Langzeitarchivierung Nationalbibliothek</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://open.fau.de/handle/openfau/10849</subfield><subfield code="x">Verlag</subfield><subfield code="z">kostenfrei</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ebook</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031294188</subfield></datafield></record></collection> |
| id | DE-604.BV045911623 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:30:07Z |
| institution | BVB |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031294188 |
| oclc_num | 1111874471 |
| open_access_boolean | 1 |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | 1 Online-Ressource |
| psigel | ebook |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| record_format | marc |
| spelling | Dörrie, Jan Verfasser aut BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft Erlangen Friedrich-Alexander-Universität Erlangen-Nürnberg 2018 1 Online-Ressource txt rdacontent c rdamedia cr rdacarrier Archivierung/Langzeitarchivierung gewährleistet DE-101 pdager BRAF inhibitor MEK inhibitor kinase inhibitor CAR-T cell dabrafenib trametinib vemurafenib cobimetinib melanoma immunotherapy Babalija, Lek Verfasser aut Hoyer, Stefanie Verfasser aut Gerer, Kerstin F. Verfasser aut Schuler, Gerold Verfasser aut Heinzerling, Lucie Verfasser aut Schaft, Niels Verfasser aut Sonderdruck aus International Journal of Molecular Sciences Vol. 19 (2018) 10.3390/ijms19010289 https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 Resolving-System kostenfrei Volltext http://d-nb.info/1186378492/34 Langzeitarchivierung Nationalbibliothek kostenfrei Volltext https://open.fau.de/handle/openfau/10849 Verlag kostenfrei Volltext |
| spellingShingle | Dörrie, Jan Babalija, Lek Hoyer, Stefanie Gerer, Kerstin F. Schuler, Gerold Heinzerling, Lucie Schaft, Niels BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy |
| title | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy |
| title_auth | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy |
| title_exact_search | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy |
| title_full | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft |
| title_fullStr | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft |
| title_full_unstemmed | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells Consequences for Adoptive T-Cell Therapy Jan Dörrie, Lek Babalija, Stefanie Hoyer, Kerstin F. Gerer, Gerold Schuler, Lucie Heinzerling, Niels Schaft |
| title_short | BRAF and MEK Inhibitors Influence the Function of Reprogrammed T Cells |
| title_sort | braf and mek inhibitors influence the function of reprogrammed t cells consequences for adoptive t cell therapy |
| title_sub | Consequences for Adoptive T-Cell Therapy |
| url | https://nbn-resolving.org/urn:nbn:de:bvb:29-opus4-108494 http://d-nb.info/1186378492/34 https://open.fau.de/handle/openfau/10849 |
| work_keys_str_mv | AT dorriejan brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT babalijalek brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT hoyerstefanie brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT gererkerstinf brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT schulergerold brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT heinzerlinglucie brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy AT schaftniels brafandmekinhibitorsinfluencethefunctionofreprogrammedtcellsconsequencesforadoptivetcelltherapy |